company background image
2183 logo

Linical TSE:2183 Stock Report

Last Price

JP¥402.00

Market Cap

JP¥9.1b

7D

0.2%

1Y

-49.5%

Updated

21 Jun, 2024

Data

Company Financials +

2183 Stock Overview

Provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide.

2183 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance2/6
Financial Health6/6
Dividends5/6

Linical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Linical
Historical stock prices
Current Share PriceJP¥402.00
52 Week HighJP¥840.00
52 Week LowJP¥374.00
Beta0.25
11 Month Change-0.25%
3 Month Change-0.50%
1 Year Change-49.50%
33 Year Change-54.63%
5 Year Change-59.64%
Change since IPO7.20%

Recent News & Updates

There May Be Some Bright Spots In Linical's (TSE:2183) Earnings

May 22
There May Be Some Bright Spots In Linical's (TSE:2183) Earnings

Recent updates

There May Be Some Bright Spots In Linical's (TSE:2183) Earnings

May 22
There May Be Some Bright Spots In Linical's (TSE:2183) Earnings

Some Linical Co., Ltd. (TSE:2183) Shareholders Look For Exit As Shares Take 26% Pounding

Mar 08
Some Linical Co., Ltd. (TSE:2183) Shareholders Look For Exit As Shares Take 26% Pounding

Linical (TSE:2183) Is Paying Out A Larger Dividend Than Last Year

Feb 26
Linical (TSE:2183) Is Paying Out A Larger Dividend Than Last Year

Shareholder Returns

2183JP Life SciencesJP Market
7D0.2%0.7%-0.04%
1Y-49.5%-39.9%16.3%

Return vs Industry: 2183 underperformed the JP Life Sciences industry which returned -39.9% over the past year.

Return vs Market: 2183 underperformed the JP Market which returned 16.3% over the past year.

Price Volatility

Is 2183's price volatile compared to industry and market?
2183 volatility
2183 Average Weekly Movement3.3%
Life Sciences Industry Average Movement4.9%
Market Average Movement3.9%
10% most volatile stocks in JP Market7.4%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 2183 has not had significant price volatility in the past 3 months.

Volatility Over Time: 2183's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005759Kazuhiro Hatanowww.linical.co.jp

Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management.

Linical Co., Ltd. Fundamentals Summary

How do Linical's earnings and revenue compare to its market cap?
2183 fundamental statistics
Market capJP¥9.08b
Earnings (TTM)JP¥338.00m
Revenue (TTM)JP¥12.31b

26.9x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2183 income statement (TTM)
RevenueJP¥12.31b
Cost of RevenueJP¥8.53b
Gross ProfitJP¥3.78b
Other ExpensesJP¥3.44b
EarningsJP¥338.00m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)14.96
Gross Margin30.69%
Net Profit Margin2.75%
Debt/Equity Ratio31.5%

How did 2183 perform over the long term?

See historical performance and comparison

Dividends

4.0%

Current Dividend Yield

100%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.